A detailed history of Dowling & Yahnke LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Dowling & Yahnke LLC holds 8,863 shares of AZN stock, worth $587,616. This represents 0.23% of its overall portfolio holdings.

Number of Shares
8,863
Previous 8,863 -0.0%
Holding current value
$587,616
Previous $586,000 17.06%
% of portfolio
0.23%
Previous 0.03%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021

BUY
$55.56 - $60.79 $20,668 - $22,613
372 Added 4.38%
8,863 $532,000
Q2 2021

Jul 21, 2021

BUY
$48.42 - $60.18 $1,258 - $1,564
26 Added 0.31%
8,491 $509,000
Q4 2020

Jan 28, 2021

BUY
$48.52 - $58.02 $410,721 - $491,139
8,465 New
8,465 $423,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $205B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Dowling & Yahnke LLC Portfolio

Follow Dowling & Yahnke LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dowling & Yahnke LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dowling & Yahnke LLC with notifications on news.